Oncology Institute Stock Forecast - Accumulation Distribution

TOI Stock  USD 3.67  0.11  3.09%   
Oncology Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Oncology Institute's historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 4th of January 2026 the relative strength index (rsi) of Oncology Institute's share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Oncology Institute's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Oncology Institute, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Oncology Institute's stock price prediction:
EPS Estimate Current Year
(0.55)
EPS Estimate Next Year
(0.28)
Wall Street Target Price
7
Quarterly Revenue Growth
0.215
Using Oncology Institute hype-based prediction, you can estimate the value of Oncology Institute from the perspective of Oncology Institute response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Oncology Institute using Oncology Institute's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Oncology using crowd psychology based on the activity and movement of Oncology Institute's stock price.

Oncology Institute Short Interest

A significant increase or decrease in Oncology Institute's short interest from the previous month could be a good indicator of investor sentiment towards Oncology. Short interest can provide insight into the potential direction of Oncology Institute stock and how bullish or bearish investors feel about the market overall.
200 Day MA
2.6873
Short Percent
0.0625
Short Ratio
2.4
Shares Short Prior Month
6.6 M
50 Day MA
3.7471

Oncology Institute Hype to Price Pattern

Investor biases related to Oncology Institute's public news can be used to forecast risks associated with an investment in Oncology. The trend in average sentiment can be used to explain how an investor holding Oncology can time the market purely based on public headlines and social activities around Oncology Institute. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Oncology Institute's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Oncology Institute.

Oncology Institute Implied Volatility

    
  1.42  
Oncology Institute's implied volatility exposes the market's sentiment of Oncology Institute stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Oncology Institute's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Oncology Institute stock will not fluctuate a lot when Oncology Institute's options are near their expiration.

Oncology Institute after-hype prediction price

    
  USD 3.66  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Oncology Institute to cross-verify your projections.
For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.The Oncology Institute's current Receivables Turnover is estimated to increase to 9.69, while Inventory Turnover is projected to decrease to 30.59. . The Oncology Institute's current Net Income Applicable To Common Shares is estimated to increase to about 64.3 K, while Common Stock Shares Outstanding is projected to decrease to under 76 M.

Open Interest Against 2026-02-20 Oncology Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Oncology Institute's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Oncology Institute's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Oncology Institute stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Oncology Institute's open interest, investors have to compare it to Oncology Institute's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Oncology Institute is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Oncology. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Oncology Institute Additional Predictive Modules

Most predictive techniques to examine Oncology price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Oncology using various technical indicators. When you analyze Oncology charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Oncology Institute has current Accumulation Distribution of 0.0734. The accumulation distribution (A/D) indicator shows the degree to which Oncology Institute is accumulated by the market over a given period. It uses the quote sensitivity to the highest or lowest daily price of Oncology Institute to determine if accumulation or reduction is taking place in the market. This value is adjusted by Oncology Institute trading volume to give more weight to distributions with higher volume over lower volume.
Check Oncology Institute VolatilityBacktest Oncology InstituteInformation Ratio  

Oncology Institute Trading Date Momentum

On January 04 2026 Oncology Institute was traded for  3.67  at the closing time. Highest Oncology Institute's price during the trading hours was 3.68  and the lowest price during the day was  3.41 . There was no trading activity during the period 0.0. Lack of trading volume on the 4th of January did not cause price change. The trading delta at closing time to current price is 3.00% .
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Oncology Institute to competition

Other Forecasting Options for Oncology Institute

For every potential investor in Oncology, whether a beginner or expert, Oncology Institute's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Oncology Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Oncology. Basic forecasting techniques help filter out the noise by identifying Oncology Institute's price trends.

Oncology Institute Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oncology Institute stock to make a market-neutral strategy. Peer analysis of Oncology Institute could also be used in its relative valuation, which is a method of valuing Oncology Institute by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Oncology Institute Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Oncology Institute's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Oncology Institute's current price.

Oncology Institute Market Strength Events

Market strength indicators help investors to evaluate how Oncology Institute stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Oncology Institute shares will generate the highest return on investment. By undertsting and applying Oncology Institute stock market strength indicators, traders can identify Oncology Institute entry and exit signals to maximize returns.

Oncology Institute Risk Indicators

The analysis of Oncology Institute's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Oncology Institute's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting oncology stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether Oncology Institute offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oncology Institute's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncology Institute Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncology Institute Stock:
Check out Historical Fundamental Analysis of Oncology Institute to cross-verify your projections.
For more detail on how to invest in Oncology Stock please use our How to Invest in Oncology Institute guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oncology Institute. If investors know Oncology will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oncology Institute listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.67)
Revenue Per Share
5.279
Quarterly Revenue Growth
0.215
Return On Assets
(0.17)
Return On Equity
(6.52)
The market value of Oncology Institute is measured differently than its book value, which is the value of Oncology that is recorded on the company's balance sheet. Investors also form their own opinion of Oncology Institute's value that differs from its market value or its book value, called intrinsic value, which is Oncology Institute's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oncology Institute's market value can be influenced by many factors that don't directly affect Oncology Institute's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oncology Institute's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncology Institute is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncology Institute's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.